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ABSTRACT The intrinsic tryptophan (Trp) fluorescence of the plasma membrane Ca2-ATPase (PMCA) is significantly
quenched by halothane, a volatile anesthetic common in clinical practice. It has been proposed that halothane inhibition of
the Ca2-ATPase activity results from conformational changes following anesthetic binding in the enzyme. We have
investigated whether the observed quenching reflects halothane binding to PMCA. We have shown that the quenching is dose
dependent and saturable and can be fitted to a binding curve with an equilibrium constant KHal  2.1 mM, a concentration
at which the anesthetic approximately half-maximally inhibits the Ca2-ATPase activity. The relatively low sensitivity of
halothane quenching of Trp fluorescence to the concentration of phosphatidylcholine and detergent in the PMCA preparation
concurs with the quenching resulting from anesthetic binding in the PMCA molecule. Analysis of the Trp fluorescence
quenching by acrylamide indicates that the Trp residues are not considerably exposed to the solvent (Stern-Volmer
quenching constant of 2.9 M1) and do not differ significantly in their accessibility to halothane. Other volatile anesthetics,
diethyl ether and diisopropyl ether, reduce the quenching caused by halothane in a dose-dependent manner, suggesting
halothane displacement from its binding site(s). These observations indicate that halothane quenching of intrinsic Trp
fluorescence of PMCA results from anesthetic binding to the protein. The analysis, used as a complementary approach,
provides new information to the still rudimentary understanding of the process of anesthetic interaction with membrane
proteins.
INTRODUCTION
The molecular site and mechanism of action of volatile
anesthetics (VAs) remain controversial. Two major hypoth-
eses have been developed that consider lipids or proteins as
molecular targets of action (for a review, see Miller, 1985;
Koblin, 1990; and Franks and Lieb, 1994). In recent years
membrane proteins have been the focus of attention. We
have previously identified an intrinsic membrane protein,
the plasma membrane Ca2-ATPase (PMCA), as a potential
target for anesthetic action (Kosk-Kosicka and Roszczyn-
ska, 1993; Kosk-Kosicka, 1994). We have suggested that
volatile anesthetics bind in hydrophobic cavities in the
protein, as has been demonstrated for small ligands such as
Xenon, whose binding to metmyoglobin affects the protein
conformation (Schoenborn and Featherstone, 1967; Tilton
et al., 1984). In PMCA, the Ca2-ATPase activity, the
Ca2-dependent conformational change that the protein un-
dergoes upon Ca2 binding in the initial step of the enzy-
matic cycle, and the intrinsic Trp fluorescence (11 Trp
residues) are affected by volatile anesthetics in a dose-
dependent manner (Lopez and Kosk-Kosicka, 1995). We
have also shown for the first time that the effects of halo-
thane on the Ca2-ATPase of the intracellular sarcoplasmic
reticulum (SERCA1) are the result of direct binding of the
anesthetic to that protein (Kosk-Kosicka et al., 1997). In the
present study we are investigating the properties and the
environment of the halothane-binding sites in the PMCA by
fluorescence spectroscopy. The quenching of the protein
intrinsic tryptophan fluorescence by volatile anesthetics has
been successfully used by Johansson et al. (1995) to mea-
sure halothane binding to bovine serum albumin. The re-
sults obtained with this approach are comparable to the ones
obtained using photoaffinity labeling (Eckenhoff and Shu-
man, 1993) and fluorine 19 NMR spectroscopy coupled
with gas chromatography partition analysis (Dubois et al.,
1993). The good correspondence between different meth-
odologies allows us to study halothane binding to PMCA by
using the protein Trp fluorescence (none of the other tech-
niques can be used for this protein partly because of its low
concentration even after purification). Our results indicate
that there is a direct interaction of the volatile anesthetic
with the plasma membrane Ca2-ATPase. The anesthetic
hydrophobic binding site(s) is not exposed to the solvent,
and halothane is displaced from the cavity(ies) in the protein
by other volatile anesthetics (ethers). The conformational
changes in the PMCA due to the interaction of the protein
with the anesthetic are not as dramatic as the changes
produced in the enzyme by urea, a protein denaturant.
MATERIALS AND METHODS
Egg yolk phosphatidylcholine (P5763) and CNBr-activated Sepharose 4B
were purchased from Sigma; octaethylene glycol mono-n-dodecyl ether
(C12E8) was obtained from Nikko (Tokyo, Japan). Coupling of bovine
calmodulin to Sepharose was performed in accordance with Pharmacia
LKB Biotechnology instructions as described earlier (Kosk-Kosicka and
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Bzdega, 1988). Thymol-free halothane was obtained from Halocarbon
Laboratories (River Edge, NJ).
The methods used for PMCA purification and protein determination
were as described previously (Kosk-Kosicka et al., 1986; Kosk-Kosicka
and Bzdega, 1988). Briefly, the enzyme was purified from erythrocyte
membrane ghosts by calmodulin affinity column chromatography in the
presence of the nonionic detergent C12E8, which led to preparations of
95% pure protein, as judged by silver staining electrophoreses. Protein
concentration was measured by Bio-Rad protein microassay. Sarcoplasmic
reticulum was prepared from rabbit skeletal muscle in the laboratory of Dr.
Inesi as described previously (Eletr and Inesi, 1972; Kosk-Kosicka et al.,
1983).
Fluorescence measurements
The tryptophan fluorescence intensity of the Ca2-ATPase was measured
at equilibrium, with a Fluoromax spectrofluorometer with DM3000F soft-
ware. Tryptophan fluorescence was excited at 290 nm, and the emission
was recorded at 330 nm. The reaction mixture contained 100 mM Tris-HCl
(pH 7.4), 0.15 mM C12E8, 120 mM KCl, 8 mM MgCl2, and 1 mM EGTA.
Free Ca2 was 17.5 M, and the protein concentration was 50–70 nM
(7–10 g/ml). In experiments with sarcoplasmic reticulum (SR), C12E8
was omitted and the protein concentration was 10 g/ml. The measure-
ments were performed at 25°C in a total volume of 1.1 ml. The aliquots of
halothane delivered to the assay were taken from solution of saturated
volatile anesthetic in the reaction mixture, which was prepared daily from
the stock of pure halothane under nitrogen gas at room temperature.
Halothane and ethers were delivered to the cuvette in an airtight Hamilton
syringe.
Determination of halothane concentration
Parallel to the fluorescence assay, samples were incubated under identical
conditions and used to determine the effective anesthetic concentration by
gas chromatography (Lopez and Kosk-Kosicka, 1997).
RESULTS
We have determined that several halogenated volatile anes-
thetics (halothane, metoxyflurane, isoflurane, and enflu-
rane) quench the intrinsic tryptophan fluorescence of the
plasma membrane Ca2-ATPase (Lopez and Kosk-Ko-
sicka, 1995). The present study focuses on the effect of
halothane on PMCA fluorescence intensity, using a wider
halothane concentration range.
As shown in Fig. 1 A (curve A), the enzyme Trp fluores-
cence decreases in a dose-dependent manner, reaching sat-
uration at 6–7 mM halothane. Considering independent and
noninteractive binding sites, the fluorescence intensity var-
ies according to the following equation:
I
Qmax halothane
kHal halothane
(1)
where I is the fluorescence intensity at any halothane con-
centration, Qmax is the maximum fluorescence that can be
quenched, and kHal is the equilibrium (dissociation) constant
for the anesthetic-protein interaction. The data points were
fitted using the nonlinear square regression method, and the
values obtained for Qmax and kHal were 1.08  0.02 and
2.1  0.1 mM, respectively. Several controls were consid-
ered. Fig. 1 A (curve B) shows the effect of halothane (up to
9 mM) on free L-tryptophan (10 M). A linear decrease of
the free Trp fluorescence was observed, with a maximum
quenching of 17  1% at 9 mM halothane. The bromine
atom in the halothane molecule is the most likely cause of
the quenching (although the chlorine atom may also con-
tribute). We measured the effect of sodium bromide on
FIGURE 1 (A) Effect of halothane (A) and NaBr (C) on PMCA Trp
fluorescence (B). Effect of halothane on free L-tryptophan fluorescence.
The reaction mixture contained 50 mM Tris-maleate (pH 7.4), 120 mM
KCl, 8 mM MgCl2, 17.5 M free Ca2, 150 M C12E8, and 1 mM EGTA.
Protein and free L-tryptophan concentrations were 50 nM and 10 M,
respectively. The experiments were performed at 25°C. (B) Hill plot for the
halothane-PMCA interaction from curve A. The slope (Hill coefficient) is
1.04  0.02. Q is the quenched fluorescence; Qmax is the maximum
fluorescence that can be quenched, as obtained from fitting curve A to Eq.
1 (under Results).
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Ca2-ATPase (50 nM) fluorescence (Fig. 1 A, curve C) and
found that 10 mM bromide ion causes a 3 1% decrease in
the enzyme Trp fluorescence. The low quenching by bro-
mide ions supports the idea that the Trp(s) in the plasma
membrane Ca2-ATPase was not exposed to the solvent.
The slight effect of the bromide ions on the enzyme fluo-
rescence also indicates that the free halothane in solution
has a minor effect on the observed quenching of the Ca2-
ATPase fluorescence.
A Hill plot of halothane binding to PMCA is shown in the
Fig. 1 B. The Hill coefficient calculated by this approach is
n  1.04  0.02, indicating that there is no cooperativity in
the halothane-PMCA interaction.
Acrylamide is known as an excellent uncharged quench-
ing probe that is very sensitive to the exposure of trypto-
phans in proteins (Eftink and Ghiron, 1976). Fig. 2 shows
the effect of acrylamide on the PMCA Trp fluorescence.
Experimental points were fitted to Eq. 2:
Io/Ii 1 KSV acrylamide (2)
where Io and Ii are the intensities in the absence and in the
presence of acrylamide, respectively, and KSV is the Stern-
Volmer quenching constant. A linear correlation is observed
between the intensities and the acrylamide concentration,
which suggests that all Trp(s) in the protein differ slightly in
accessibility (Eftink and Ghiron, 1976). KSV, obtained from
the slope, is 2.9  0.1 M1. The collisional quenching
constant, obtained as kq  KSV/, where  is the lifetime of
the Trp in the absence of acrylamide, is 5.9  0.3 	 108
M1 s1 ( 4.9 ns, from Lopez and Kosk-Kosicka, 1995).
We compared the effect of acrylamide on PMCA and
SERCA1 (Fig. 2) for several reasons. SERCA1 and PMCA
are similar enzymes, and the former has been studied ex-
tensively by numerous laboratories. Based on hydrophobic-
ity plots, immunological localization of epitopes, chemical
derivatization, and fluorescence spectroscopy measure-
ments, substantial progress has been made in predicting its
three-dimensional structure (for a review, see Inesi et al.,
1990; Stokes et al., 1994; and Andersen and Vilsen, 1995).
It appears that in SERCA1, 12 of 13 Trp are located near the
membrane interface. Thus the comparison of the acrylamide
effect on PMCA and SERCA1 may provide useful infor-
mation about the PMCA Trp(s) environment.
We also observe a linear correlation between the inten-
sities and the acrylamide concentrations for SERCA1, and
the KSV of 1.9  0.5 M1 is very comparable to the value
obtained by Gryczynski et al. (1989) (KSV  1.6 M1).
The small Stern-Volmer constant, meaning low accessi-
bility to the quencher (Eftink and Ghiron, 1976), and the
fact that all Trp(s) are equally accessible to the quencher
support once more the theory that the Trp(s) in the PMCA
and SERCA1 are not exposed to the solvent.
To assess if the effect of volatile anesthetics on their
targets is similar to the effect of denaturants, we have
included in our study the effect of the protein denaturant
urea on the PMCA Trp fluorescence. Fig. 3 shows that urea
also quenches the enzyme intrinsic fluorescence in a dose-
dependent manner (2, 4, and 8 M urea quenched PMCA Trp
fluorescence intensity by 8, 18, and 24 2%, respectively).
Another effect observed in the presence of certain urea
concentrations is a shift in the maximum of the emission
spectra: 8 M urea produces a 5–6-nm red shift (Fig. 3, curve
FIGURE 2 Effect of acrylamide on the PMCA (f) and SERCA1 ()
intrinsic tryptophan fluorescence. The protein concentration in both cases
was 10 g/ml. Data points were fitted to Eq. 2 (under Results). Experi-
mental conditions were as described in Fig. 1.
FIGURE 3 Fluorescence emission spectra of PMCA in the absence (A)
and presence of 2 M (B), 4 M (C), and 8 M (D) urea. The excitation
wavelength was 290 nm. Protein concentration was 65 nM. Experimental
conditions were as described in Fig. 1.
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D), indicating that under these experimental conditions the
environment of the Trp(s) becomes more polar, as expected
upon unfolding of the protein.
We then studied the possible influence of different phos-
phatidylcholine (PC) and C12E8 concentrations on the Ca2-
ATPase fluorescence quenching by halothane. Table 1
shows that the enzyme Trp fluorescence quenching in sam-
ples without PC or in samples with 40 M PC (our standard
experimental conditions) differs by only 5%, whereas in
samples with 200 M PC, the difference, with respect to our
standard conditions, is
10%. These results suggest that the
volatile anesthetic interacts mainly with the protein. Table 2
shows that the extent of PMCA Trp fluorescence quenched
by 4.3 mM halothane decreases slightly when the C12E8 and
PC concentrations are two- and fourfold higher than in our
standard experimental conditions (150 M C12E8 and 40
M PC). From these results we conclude that the effects of
detergent and lipids are very comparable and do not con-
tribute significantly to the observed effect of halothane on
the PMCA Trp fluorescence.
The nonpolar sites in proteins are limited in size and
shape. Thus we have studied the effects of diethyl and
diisopropyl ether (which by themselves do not affect the
PMCA intrinsic Trp fluorescence) on the enzyme fluores-
cence quenching by halothane. At saturated halothane con-
centrations (7.1 mM), increasing the diethyl and diisopropyl
ether concentrations decreases the halothane quenching
(Fig. 4). These results suggest that halothane could be
displaced from its binding site(s) in the protein. We also
observe that the effect of diisopropyl ether is larger than the
effect of diethyl ether: in the presence of 9% (v/v) diiso-
propyl or diethyl ether, the halothane quenching observed is
42% and 61%, respectively (versus 80% in the absence of
any ether) (Fig. 4). Thus different ethers may have different
competitive binding constants when interacting with PMCA
in the presence of halothane.
DISCUSSION
We have shown that halothane quenches the PMCA Trp
fluorescence in a saturable manner. We interpret the
quenching effect to be a result of a direct interaction (al-
though weak, KHal in mM range) between halothane and the
PMCA based on the following findings: 1) 7 mM halothane
quenches the PMCA Trp fluorescence by 80%, whereas it
quenches the free Trp fluorescence by only 10–12%; 2) the
halothane quenching of the protein fluorescence can be
fitted to a binding curve, whereas the halothane quenching
of the free Trp fluorescence follows a linear correlation,
characteristic of nonspecific binding; 3) there is a strong
correlation between the halothane concentration that half-
maximally inhibits the Ca2-ATPase activity (I50  2.6
mM; Lopez and Kosk-Kosicka, 1995) and the equilibrium
constant obtained from the quenching experiments (KHal 
2.1 mM). Similar spectroscopic results have been obtained
for the interaction of halothane with bovine serum albumin,
whereas no significant fluorescence quenching has been
observed for another protein (apomyoglobin) (Johansson et
al., 1995). Other proteins have been shown, by photoaffinity
labeling, to saturably bind halothane: the Ca2-ATPase in
the sarcoplasmic reticulum (Kosk-Kosicka et al., 1997) and
rat brain synaptosomes (El-Maghrabi et al., 1992).
Several observations have led us to conclude that the
PMCA Trp(s) are not exposed to the solvent: 1) bromide
ions do not quench the PMCA Trp fluorescence signifi-
cantly (water-soluble heavy atoms are known to have little
access to buried tryptophanyl residues; Bogomolni et al.,
TABLE 1 Effect of phosphatidylcholine on halothane
quenching of PMCA tryptophan fluorescence
[Halothane]
(mM)
Quenching (%)
No PC 40 M PC 200 M PC
1.43 42 43 40
2.85 58 62 56
4.28 68 72 65
5.71 75 79 ND
7.14 80 81 ND
ND, Not done.
TABLE 2 Effect of C12E8 and phosphatidylcholine on
halothane quenching of the tryptophan fluorescence in the
PMCA
[C12E8] (M) [PC] (M) Quenching (%)
150 40 72
300 40 64
150 150 63
The halothane concentration was 4.3 mM.
FIGURE 4 Effect of diethyl ether () and diisopropyl ether () on
halothane quenching of PMCA Trp fluorescence. Halothane concentration
was 7.1 mM. Experimental conditions were as described in Fig. 1. The line
through the data points was generated by linear regression analysis.
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1978); 2) the PMCA fluorescence emission spectrum has a
maximum at 330 nm (Lopez and Kosk-Kosicka, 1995),
which is characteristic of Trp(s) residues buried in the
protein (Burstein et al., 1973; Lakowicz, 1991); 3) the
dynamic quenching experiments with acrylamide show a
linear Stern-Volmer plot, suggesting that all Trp differ
slightly in accessibility (Eftink and Ghiron, 1976). The
Stern-Volmer quenching constants for the acrylamide inter-
action with PMCA and SERCA1 are similar (2.9 and 1.9
M1, respectively). The low KSV value obtained for
SERCA1 agrees with the fact that most of its Trp(s) are in
the membrane. Both enzymes have Stern-Volmer quench-
ing constants that are comparable to other multitryptophan
proteins (for trypsin KSV 2.4 M1, trypsinogen KSV 2.3
M1; Eftink and Ghiron, 1976). For proteins in which the
Trp(s) are fairly exposed to the quencher, higher Stern-
Volmer quenching constants are obtained (i.e., pepsin
KSV 9.5 M1, papain KSV 8.0 M1; Eftink and Ghiron,
1976).
In conclusion, it appears that most of the tryptophans in
the plasma membrane Ca2-ATPase are not considerably
exposed to the solvent. This result is in agreement with the
expected membrane organization of the enzyme (based on
the model for SR Ca2-ATPase; MacLennan et al., 1985)
and with the enzyme predicted secondary structure (based
on the alignment of transport ATPases; Carafoli and Chiesi,
1992; Carafoli, 1994).
Comparison of the quenching effects of volatile
anesthetics and the denaturant urea
We have shown that the effect of VA on the plasma mem-
brane Ca2-ATPase bears some resemblance to the effect of
urea on this enzyme. The fact that similar effects have been
observed for other proteins led to the suggestion that anes-
thetics might behave as denaturants (Mitaku et al., 1995).
Among the similarities, we found that volatile anesthetics
and urea quench the PMCA Trp fluorescence, produce a red
shift in the maximum of the emission spectra, and inhibit the
Ca2-ATPase activity (Lopez and Kosk-Kosicka, 1995;
Kosk-Kosicka et al., 1994; Fig. 3). However, volatile anes-
thetics and the denaturant urea differ in the extent of
quenching, the conformational changes they produce, and
the correlation between quenching and loss of the PMCA
activity. We have observed that 8 M urea (under these
conditions most proteins are considered unfolded) quenches
the PMCA Trp fluorescence by 24%, and the maximum of
the emission spectrum is red shifted by 
5 nm. However,
the enzyme activity is already completely inhibited at 2 M
urea (Kosk-Kosicka et al., 1994), which quenches the pro-
tein Trp fluorescence by only 6–8% and produces no red
shift in the maximum of the emission spectrum (Fig. 3). So
the Ca2-ATPase activity is affected at a much lower urea
concentration than that required to unfold the protein. Such
differences in concentration required for inhibition of the
enzyme activity and protein unfolding have also been re-
ported for other enzymes (Zhou et al., 1993; West et al.,
1990). In contrast to describing anesthetic action on proteins
as denaturating, we have proposed that binding of volatile
anesthetics perturbs conformational substate(s) of the
enzyme, leading to the observed inhibition of the Ca2-
ATPase activity (Lopez and Kosk-Kosicka, 1995). The
good correlation between the changes in the conformation
of the protein (followed by fluorescence spectroscopy) and
the loss of enzyme activity supports this idea. Another
important difference between denaturants and volatile an-
esthetics is that the unfolding process for PMCA is irrevers-
ible (as it is for most membrane proteins; for a review see
Haltia and Freire, 1995; for SERCA1 see Lepock et al.,
1990 and Merino et al., 1994): the enzyme activity is not
recovered after heat denaturation. The effect of volatile
anesthetics is reversible: the Ca2-ATPase activity is recov-
ered after evaporation of the anesthetic (Kosk-Kosicka and
Roszczynska, 1993).
Thus the anesthetics’ effects on PMCA may not be sim-
ilar to the effect of denaturants: 1) the conformational
changes in the protein due to the anesthetic binding are not
drastic and are well correlated with the impairment of the
enzyme activity, as opposed to the denaturant effects; and 2)
the anesthetic-protein interaction is a reversible process,
whereas the unfolding process of the protein is not.
Effect of lipids and detergent on the PMCA
fluorescence quenching by halothane
The long-accepted theory that the effect of volatile anes-
thetics is through lipids has been changing. We have shown
that different PC concentrations seem to affect the halothane
quenching very little (the increase of PC concentration by
fivefold with respect to our standard experimental condi-
tions (200 M and 40 M, respectively) decreases halo-
thane quenching by only 10–12%; Table 1). These results
agree with our hypothesis that the anesthetics interact di-
rectly with the protein. We have been able to prove this for
the Ca2-ATPase in the sarcoplasmic reticulum by using
photoaffinity labeling: up to 50% of [14C]halothane is in-
corporated into the enzyme (Kosk-Kosicka et al., 1997).
On the other hand, we have to consider that the PMCA
used in this study is a purified enzyme that contains deter-
gent. We have shown that the effect of C12E8 on the halo-
thane quenching is very comparable to the PC effect: in the
range of concentrations studied, either detergent or lipids
decrease the halothane quenching by a maximum of 10–
12%. These results suggest that under our experimental
conditions, the quencher does not partition overwhelmingly
into the lipid or micellar phase, or if it does, the excess
anesthetic left is enough to quench the protein fluorescence
and is not dramatically dependent on the PC or C12E8
concentrations. Different observations have been published
for the interaction of bromostearate with spectrin (Kahana et
al., 1992): quenching of spectrin fluorescence by bromoste-
arate is totally suppressed by low concentrations of nonionic
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detergent and by the presence of vesicles. The authors
conclude that the ligand partitions entirely into the micellar
phase or vesicles, respectively.
Reversibility of PMCA-halothane interaction
by ethers
We have shown that two nonquenching anesthetics, diethyl
and diisopropyl ether, can reverse in part the halothane
quenching effect on PMCA fluorescence. At saturated hal-
othane concentration (7.1 mM), 22–23% (v/v) of diethyl
ether is needed to inhibit the halothane quenching by 50%
(Fig. 4). The observed apparent competition between halo-
thane and diethyl ether may indicate that the two anesthetics
bind in the same hydrophobic cavity(ies) in the protein, or
that diethyl ether binds in a different place but affects
halothane binding, significantly decreasing PMCA affinity
for halothane. Halothane displacement from its binding site
by diethyl ether has also been shown for a globular protein
(BSA) (Johansson et al., 1995). On the other hand, Raines
and McClure did not observe any significant effect of di-
ethyl ether on the halothane quenching of the nicotinic
acetylcholine receptor’s (nAcChoR’s) Trp fluorescence
(Raines and McClure, 1997). This result may be just a
consequence of their experimental design: 1 mM halothane
quenches nAcChoR’s Trp fluorescence by 
10%, so if
diethyl ether binds in the same place as halothane, but with
a lower affinity, the diethyl ether binding to the protein in
the presence of 1 mM halothane would not affect the hal-
othane quenching. On the contrary, if the protein is satu-
rated with halothane, it is easier to observe competition
between the two volatile anesthetics.
We have also observed that another ether (diisopropyl
ether) competes with halothane, but has a much larger effect
on halothane quenching than diethyl ether (Fig. 4). This
result may indicate that PMCA affinity for diisopropyl ether
is higher than the affinity for diethyl ether. We have already
shown that PMCA binds another general anesthetic (propo-
fol) with an affinity that is one to two orders of magnitude
higher than that of halothane (Lopez and Kosk-Kosicka,
1997). Propofol is a larger molecule than halothane (ratio of
volumes 
1.8), and the interaction of the former with the
protein is more favorable thermodynamically because of a
higher entropy change upon propofol binding (Lopez and
Kosk-Kosicka, 1997). As we have shown that the anes-
thetic–Ca2-ATPase interaction is an entropy-driven pro-
cess, most probably the entropy change that occurs upon
diisopropyl ether binding to the enzyme is greater than for
diethyl ether (the ratio of the volumes for the ether mole-
cules is 
1.4), which would explain the difference in the
PMCA affinity for the two ethers.
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